Balchem Corp

Basic Materials · Chemicals - Specialty

Overall research band Mixed

Quality Mixed

Valuation Mixed

Balance sheet Strong

Market confirmation Weak

One-minute company read

What this report can tell you now

What the company does

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. The company operates through three segments: Human Nutrition and Health, which supplies ingredients such as spray dried and emulsified powders, blended lipid systems, and specialty vitamin K2 for the food and beverage industry; Animal Nutrition and Health, which provides microencapsulated products, chelation technology, methylsulfonylmethane, and choline chloride for animal health and nutrition; and Specialty Products, which distributes ethylene oxide and ammonia for healthcare sterilization, single use canisters, and propylene oxide for fumigation and contamination control in food products. Balchem sells its products through a combination of direct sales force, independent distributors, and sales agents.

The current research profile is Mixed Setup, with weak market confirmation. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC12.7%Model input; read with the evidence status and period context.

Operating margin21.1%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years6.7%Model input; read with the evidence status and period context.

FCF margin16.7%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.